Importantly, the slamf7-/--Clo mice exhibited more severe colitis than the slamf7-/- mice did following DSS treatment, while there were no differences in body weight, colon length, or mortality between the slamf7−/--Clo and WT-Clo mice (Figure 4(j-l)). The gene discussed is SLAMF7; the disease is colitis.